nct02637284 bpc-157 A human trial was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo-controlled clinical trial (NCT02637284) was launched BPC-157 Dosage And Research Protocol
Description
Your immune system patrols your bloodstream

Possible Side Effects Mild injection site reaction (transient) Rare: temporary skin discoloration at injection site Very low systemic side effect profile No hormonal effects Important: GHK-Cu has an extensive safety record across decades of research in cosmetic and medical applications

doi: 10.1182/blood-2017-10-809293 43 BuschLMougiakakosDBttner-HeroldMMllerMJVolmerDABachCet al

When applied, ATTDX BPC-157 TriMag Complex Joint Therapy Cream penetrates through the skin and reaches surrounding nerves and tissues